BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26122829)

  • 1. Shedding New Light on the Use of Imaging Technology for Glioblastoma Tumor Resection.
    Nemunaitis J; Senzer N
    Mol Ther; 2015 Jul; 23(7):1136-1137. PubMed ID: 26122829
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
    Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided operation in recurrent glioblastoma multiforme treated with bevacizumab-fluorescence of the noncontrast enhancing tumor tissue?
    Wachter D; Kallenberg K; Wrede A; Schulz-Schaeffer W; Behm T; Rohde V
    J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):401-6. PubMed ID: 22777926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of surgical resection in recurrent glioblastoma.
    Vogelbaum MA
    Neuro Oncol; 2016 Apr; 18(4):462-3. PubMed ID: 26869588
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
    Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
    Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
    [No Abstract]   [Full Text] [Related]  

  • 8. Reoperation for Recurrent Glioblastoma Multiforme.
    Robin AM; Lee I; Kalkanis SN
    Neurosurg Clin N Am; 2017 Jul; 28(3):407-428. PubMed ID: 28600015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice.
    Bianco J; Bastiancich C; Joudiou N; Gallez B; des Rieux A; Danhier F
    J Neurosci Methods; 2017 Jun; 284():96-102. PubMed ID: 28472680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.
    Cage TA; Pekmezci M; Prados M; Berger MS
    J Neurosurg; 2013 Jun; 118(6):1220-3. PubMed ID: 23421452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
    Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
    J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-do craniotomy for recurrent glioblastoma.
    Morsy AA; Ng WH
    CNS Oncol; 2015; 4(2):55-7. PubMed ID: 25768328
    [No Abstract]   [Full Text] [Related]  

  • 13. Operative cytoreduction for recurrent glioblastoma.
    Morton RP; Nerva JD; Abecassis IJ; Silbergeld DL; Kim LJ
    World Neurosurg; 2014 Dec; 82(6):929-31. PubMed ID: 25311979
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: glioblastoma and surgery.
    Shaikhouni A; Chiocca EA
    J Neurosurg; 2013 Apr; 118(4):809-11; discussion 810-1. PubMed ID: 23082887
    [No Abstract]   [Full Text] [Related]  

  • 15. Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?
    Adeberg S; Diehl C; Jung CS; Rieken S; Combs SE; Unterberg A; Debus J
    J Neurooncol; 2016 May; 127(3):581-7. PubMed ID: 26830090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of surgery on recurrence pattern of glioblastoma.
    De Bonis P; Anile C; Pompucci A; Fiorentino A; Balducci M; Chiesa S; Lauriola L; Maira G; Mangiola A
    Clin Neurol Neurosurg; 2013 Jan; 115(1):37-43. PubMed ID: 22537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Glioblastoma multiforme and laser interstitial thermal therapy.
    Elder JB; Chiocca EA
    J Neurosurg; 2013 Jun; 118(6):1199-200; discussion 1200-1. PubMed ID: 23560576
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotactic radiosurgery for glioblastoma--time to revisit this approach.
    Sheehan J
    World Neurosurg; 2012 Dec; 78(6):592-3. PubMed ID: 22641184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intraoperative radiotherapy by means of a photon radiosurgical system (PRS400) after removal of recurring glioblastoma].
    Colombo F; Francescon P; Cavedon C
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (3):39-40. PubMed ID: 18041212
    [No Abstract]   [Full Text] [Related]  

  • 20. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.